Imris Inc (IMRS) 0.02 $IMRS
IMRIS Announces Receipt of Nasdaq Notice of Delisting
PR Newswire - Mon Jun 01, 2:34PM CDT
IMRIS Inc.(the Company)(NASDAQ: IMRS; TSX: IM) announced today that the Company received a letter May 26, 2015 from the NASDAQ Stock Market LLC ("Nasdaq"
stating that in accordance with Listing Rules 5101, 5110(b), and IM-5101-1, the Staff has determined that the Company's securities will be delisted from The NASDAQ Stock Market. Accordingly, trading of the Company's Common Shares will be suspended at the opening of business on June 4, 2015, and a Form 25-NSE will be filed with the Securities and Exchange Commissions (the SEC), which will remove the Company's securities from listing and registration on The Nasdaq Stock Market. The Nasdaq staff determination was based on the following factors: the associated public interest concerns raised by the Company's press release dated May 26, 2015 in which the Company announced it has filed for protection under Chapter 11 of the U.S. Bankruptcy Code; concerns regarding the residual equity interest of the existing listed securities holders; and concerns about the Company's ability to sustain compliance with all requirements for continued listing on The Nasdaq Stock Market.
IMRS: 0.02 (-0.01), IM.TO: 0.72 (-0.02)
Closed MRI Systems Market 2015 by Field Strength & by Application - Global Forecast to 2019
M2 - Wed May 27, 9:53AM CDT
Research and Markets (http://www.researchandmarkets.com/research/bsd924/closed_mri) has announced the addition of the "Closed MRI Systems Market, by Field Strength (Low-to-Mid Field, High Field, Very High Field, Ultra High Field) & by Application (Brain, Spine, Cardiac, Breast, Abdominal) -Global Forecast to 2019" report to their offering. The purpose of this report is to cover the definition, description, and forecast of the global MRI system market. It involves deep dive analysis of market segmentation that encompasses field strength, application, and geography. This report also offers strategic insights of key players thriving in this market. The global closed MRI systems market by field strength is segmented into low-to-mid field MRI, high field MRI, very high field MRI, and ultra-high field MRI. Major applications of this market include spine & musculoskeletal MRI, brain & neurological MRI, vascular MRI, pelvic & abdominal MRI, breast MRI, and cardiac MRI. Globally, the closed MRI systems market in North America is projected to grow at a CAGR of 4.8% from 2014 to 2019. This growth is mainly attributed to rise in aging population and growing awareness among people about the benefits associated with MRI scanning. Presently, MRI is the most commonly used non-invasive imaging modality for early diagnosis and screening of various diseases, such as multiple sclerosis (MS), dementia, breast cancer, prostate cancer, spinal tuberculosis, and Alzheimer. This will further improve the overall demand for closed MRI systems all around the world. Furthermore, advancements in MRI techniques include superconducting (SC) magnets, open architecture, high-field MRI, and software applications. The advent of MRI-compatible pacemakers will significantly increase the number of patients eligible for MRI procedures. However, high cost of MRI systems, reduction in the availability of helium that could force hospitals to replace costly MRI magnets, and declining reimbursement rates for MRI procedures are factors restraining the growth of the closed MRI system market. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Market Overview 5 Closed MRI Systems Market, By Field Strength 6 Closed MRI Systems Market, By Application 7 Closed MRI Systems Market, By Geography 8 Closed MRI Systems Market: Competitive Landscape 9 Closed MRI Systems Market, By Company - Aurora Imaging Technology, Inc. - Esaote S.P.A - Fonar Corporation - GE Healthcare - Hitachi Medical Corporation - Imris, Inc. - Neusoft Medical Systems Co., Ltd. (Neusoft Medical) - Philips Healthcare - Siemens Healthcare - Toshiba Medical Systems Corporation (Part of Toshiba Corporation) For more information visit http://www.researchandmarkets.com/research/bsd924/closed_mri
IMRS: 0.02 (-0.01), MDSY: 1.50 (+0.01)
IMRIS Inc. and Two Subsidiaries File for Chapter 11 Protection
CNW Group - Tue May 26, 7:26AM CDT
Company Reaches Agreement With Deerfield Management Company, L.P. to Provide Debtor-In-Possession Financing and Purchase All Operating Businesses
IMRS: 0.02 (-0.01), IM.TO: 0.72 (-0.02)
IIROC Trade Halt - IMRIS Inc.
Newsfile Corp - Tue May 26, 7:24AM CDT
The following issues have been halted by IIROC:
IMRS: 0.02 (-0.01)
IMRIS Executive Vice Presidents of Global Sales and Global Customer Service Leave the Company
CNW Group - Tue May 19, 6:01AM CDT
IMRIS Inc. (NASDAQ: IMRS; TSX: IM) today announced that Mike Fritts, Executive Vice President, Global Customer Service, and Mark Reade, Executive Vice President, Global Sales, have left the Company. Mr. Fritts departed effective May 15, 2015 and has served as IMRIS' EVP of Global Customer Service since 2013. Mr. Reade departed effective May 16, 2015 and has served as IMRIS' EVP of Global Sales since 2010.
IMRS: 0.02 (-0.01), IM.TO: 0.72 (-0.02)
IMRIS Announces Correction of Annual Meeting Record Date to May 15, 2015
PR Newswire - Thu May 07, 3:31PM CDT
IMRIS Inc. (NASDAQ: IMRS; TSX: IM) ("IMRIS" or the "Company" announces a correction to yesterday's press release which stated that the Company's shareholders of record on May 14, 2015 will be entitled to notice and to vote at the Annual Meeting. The record date is May 15, 2015 instead of May 14, 2015.
IMRS: 0.02 (-0.01), IM.TO: 0.72 (-0.02)
IMRIS Announces Postponement of its Annual Meeting of Shareholders and Release of First Quarter 2015 Financial Results and Conference Call
PR Newswire - Wed May 06, 1:57PM CDT
IMRIS Inc. (NASDAQ: IMRS; TSX: IM) ("IMRIS" or the "Company" today announced that the Annual Meeting of Shareholders, which was scheduled for May 7th, 2015, has been rescheduled to June 25th, 2015. IMRIS also announced that the First Quarter 2015 Financial Results press release and conference call, which were scheduled for May 7th, 2015, have been postponed. Further details regarding the meeting of shareholders will be contained in the Information Circular that will be mailed to shareholders of the Company in due course.
IMRS: 0.02 (-0.01), IM.TO: 0.72 (-0.02)
IMRIS to Hold First Quarter 2015 Financial Results Conference Call
PR Newswire - Wed Apr 29, 4:45PM CDT
IMRIS Inc. (NASDAQ: IMRS; TSX: IM) IMRIS Inc. (the "Company" or "IMRIS" is scheduled to release the Company's first quarter 2015 financial results on Thursday, May 7 at 8:00 a.m. Eastern time. A teleconference and a live webcast are scheduled that day from 9:00 to 10:00 a.m. Eastern time. You may join the teleconference by calling 1-800-505-9573 (US/CAN) or 1-416-204-9498 (Int'l), use conference ID 7822293. You may access the live webcast at www.imris.com/investors/events-and-presentations.
IMRS: 0.02 (-0.01), IM.TO: 0.72 (-0.02)
North American Intraoperative Imaging Market by Type (Intraoperative CT, Intraoperative MRI, Intraoperative Ultrasound) - Forecast to 2019 with Medtronic Inc., Siemens AG, Brainlab AG Dominating
M2 - Tue Apr 28, 8:05AM CDT
Research and Markets (http://www.researchandmarkets.com/research/qnj4sj/north_american) has announced the addition of the "North American Intraoperative Imaging Market by Type (Intraoperative CT, Intraoperative MRI, Intraoperative Ultrasound) - Forecast to 2019" report to their offering. The Intraoperative Imaging market in North America is growing at 1.8% annually, with the U.S. having the largest market share and CAGR of 1.2 % among all countries, followed by Canada and Mexico The market has been divided into Intraoperative CT, Intraoperative MRI, and intraoperative ultrasound, wherein the intraoperative CT segment has highest market share while intraoperative MRI segment shows the highest growth rate among all three segments. There have been numerous opportunities for the market and the market players to grow and expand substantially. For example, Siemens AG shared its technology to integrate the hybrid suites and surgical theatre to enhance the operational efficiency of Sahlgrenaka University Hospital, one of the largest hospitals in Western Europe. There have been several collaborations among different market players to share their technologies and contribute to market growth. In addition, it is projected that the number of surgeries as well as healthcare expenditure will increase in coming years, which would have a positive impact on the growth of this market. However, high cost of automation is a factor that may inhibit the growth of this market in coming year. The report identified and analyses the various submarkets and highlights the high growth segments in this region. In addition, it includes profiles of the various companies operating in this market, along with a comprehensive analysis of the developments undertaken by them in recent years The key market players listed in this report include Medtronic Inc., Siemens AG, Brainlab AG, and others. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Market Overview 5 North Amrica Intraoperative Imaging Market, By Type 6 Intraoperative Imaging Market, By Country 7 Intraoperative Imaging Market: Competitive Landscape 8 Intraoperative Imaging Market, By Company - Brainlab Ag - Imris Inc. - Medtronic Plc - Neurologica Corporation - Philips Healthcare (A Subsidiary Of Royal Philips Electronics) - Siemens Ag For more information visit http://www.researchandmarkets.com/research/qn...h_american
PHG: 26.83 (+0.66), MDT: 85.51 (+1.25), IMRS: 0.02 (-0.01)
IMRIS Announces Receipt of Nasdaq Notice of Bid Price Deficiency
CNW Group - Wed Apr 22, 4:28PM CDT
IMRIS Inc. (NASDAQ: IMRS; TSX: IM) announced today that the Company received a letter, dated April 20, 2015, from the NASDAQ Stock Market LLC ("Nasdaq" stating that for the previous 30 consecutive business days the bid price of the Company's common stock closed below the minimum $1.00 per share required for continued listing under Nasdaq Listing Rule 5450(a)(1).
IMRS: 0.02 (-0.01), IM.TO: 0.72 (-0.02)
Leading neurosurgeons speaking on clinical utility of real-time navigated laser therapy for lesion ablation within Intraoperative MRI Suites at AANS
PR Newswire - Wed Apr 15, 7:25AM CDT
IMRIS, Monteris & MRI Interventions sponsoring luncheon seminar
IMRS: 0.02 (-0.01), IM.TO: 0.72 (-0.02)
Magnetic Resonance Imaging (MRI) Equipment - Global Strategic Business Report 2015-2020: GE Healthcare's Silent Scan Technology: A Major Technological Breakthrough
M2 - Wed Apr 01, 3:55AM CDT
Research and Markets (http://www.researchandmarkets.com/research/k89rwd/magnetic) has announced the addition of the "Magnetic Resonance Imaging (MRI) Equipment - Global Strategic Business Report" report to their offering. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. This report analyzes the worldwide markets for Magnetic Resonance Imaging (MRI) Equipment in Units and US$ Million by the following Product Segments: - Closed MRI Systems - Open MRI Systems. The US Market for MRI Equipment is separately analyzed by the following segments, categorized by magnetic field strength: - Low & Mid-Field Systems - High Field Systems - Very High-Field Systems. The report profiles 36 companies including many key and niche players such as: - China Resources Wandong Medical Equipment Co., Ltd. (China) - Esaote SPA (Italy) - FONAR Corporation (USA) - GE Healthcare (UK) - Hitachi Medical Corporation (Japan) - IMRIS, Inc. (US) - Medinus Co., Ltd. (South Korea) - Medtronic, Inc. (USA) - Philips Healthcare (US) - Shenzhen Anke High-tech Co., Ltd. (China) - Siemens Healthcare (Germany) - Toshiba Medical Systems Corp. (Japan) - Toshiba America Medical Systems, Inc. (US) Key Topics Covered: 1. MARKET OVERVIEW 2. MARKET TRENDS/DRIVERS/ISSUES 3. MRI EQUIPMENT: PRODUCT OVERVIEW 4. UTILITIES OF MRI EQUIPMENT 5. VERY HIGH FIELD SYSTEMS REDEFINING EFFICIENCY 6. COMPETITIVE IMAGING TECHNOLOGIES 7. PRODUCT INTRODUCTIONS/INNOVATIONS/ APPROVALS 8. RECENT INDUSTRY ACTIVITY 9. FOCUS ON SELECT PLAYERS 10. GLOBAL MARKET PERSPECTIVE Total Companies Profiled: 36 (including Divisions/Subsidiaries (51) - The United States (15) - Canada (1) - Japan (2) - Europe (19) - France (1) - Germany (6) - The United Kingdom (3) - Italy (2) - Rest of Europe (7) - Asia-Pacific (Excluding Japan) (12) - Middle East (2) For more information visit http://www.researchandmarkets.com/research/k89rwd/magnetic
MDT: 85.51 (+1.25), IMRS: 0.02 (-0.01), MDSY: 1.50 (+0.01)
IMRIS Announces Receipt of Nasdaq Notice of Delisting
PR Newswire - Mon Jun 01, 2:34PM CDT
IMRIS Inc.(the Company)(NASDAQ: IMRS; TSX: IM) announced today that the Company received a letter May 26, 2015 from the NASDAQ Stock Market LLC ("Nasdaq"
stating that in accordance with Listing Rules 5101, 5110(b), and IM-5101-1, the Staff has determined that the Company's securities will be delisted from The NASDAQ Stock Market. Accordingly, trading of the Company's Common Shares will be suspended at the opening of business on June 4, 2015, and a Form 25-NSE will be filed with the Securities and Exchange Commissions (the SEC), which will remove the Company's securities from listing and registration on The Nasdaq Stock Market. The Nasdaq staff determination was based on the following factors: the associated public interest concerns raised by the Company's press release dated May 26, 2015 in which the Company announced it has filed for protection under Chapter 11 of the U.S. Bankruptcy Code; concerns regarding the residual equity interest of the existing listed securities holders; and concerns about the Company's ability to sustain compliance with all requirements for continued listing on The Nasdaq Stock Market. IMRS: 0.02 (-0.01), IM.TO: 0.72 (-0.02)
Closed MRI Systems Market 2015 by Field Strength & by Application - Global Forecast to 2019
M2 - Wed May 27, 9:53AM CDT
Research and Markets (http://www.researchandmarkets.com/research/bsd924/closed_mri) has announced the addition of the "Closed MRI Systems Market, by Field Strength (Low-to-Mid Field, High Field, Very High Field, Ultra High Field) & by Application (Brain, Spine, Cardiac, Breast, Abdominal) -Global Forecast to 2019" report to their offering. The purpose of this report is to cover the definition, description, and forecast of the global MRI system market. It involves deep dive analysis of market segmentation that encompasses field strength, application, and geography. This report also offers strategic insights of key players thriving in this market. The global closed MRI systems market by field strength is segmented into low-to-mid field MRI, high field MRI, very high field MRI, and ultra-high field MRI. Major applications of this market include spine & musculoskeletal MRI, brain & neurological MRI, vascular MRI, pelvic & abdominal MRI, breast MRI, and cardiac MRI. Globally, the closed MRI systems market in North America is projected to grow at a CAGR of 4.8% from 2014 to 2019. This growth is mainly attributed to rise in aging population and growing awareness among people about the benefits associated with MRI scanning. Presently, MRI is the most commonly used non-invasive imaging modality for early diagnosis and screening of various diseases, such as multiple sclerosis (MS), dementia, breast cancer, prostate cancer, spinal tuberculosis, and Alzheimer. This will further improve the overall demand for closed MRI systems all around the world. Furthermore, advancements in MRI techniques include superconducting (SC) magnets, open architecture, high-field MRI, and software applications. The advent of MRI-compatible pacemakers will significantly increase the number of patients eligible for MRI procedures. However, high cost of MRI systems, reduction in the availability of helium that could force hospitals to replace costly MRI magnets, and declining reimbursement rates for MRI procedures are factors restraining the growth of the closed MRI system market. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Market Overview 5 Closed MRI Systems Market, By Field Strength 6 Closed MRI Systems Market, By Application 7 Closed MRI Systems Market, By Geography 8 Closed MRI Systems Market: Competitive Landscape 9 Closed MRI Systems Market, By Company - Aurora Imaging Technology, Inc. - Esaote S.P.A - Fonar Corporation - GE Healthcare - Hitachi Medical Corporation - Imris, Inc. - Neusoft Medical Systems Co., Ltd. (Neusoft Medical) - Philips Healthcare - Siemens Healthcare - Toshiba Medical Systems Corporation (Part of Toshiba Corporation) For more information visit http://www.researchandmarkets.com/research/bsd924/closed_mri
IMRS: 0.02 (-0.01), MDSY: 1.50 (+0.01)
IMRIS Inc. and Two Subsidiaries File for Chapter 11 Protection
CNW Group - Tue May 26, 7:26AM CDT
Company Reaches Agreement With Deerfield Management Company, L.P. to Provide Debtor-In-Possession Financing and Purchase All Operating Businesses
IMRS: 0.02 (-0.01), IM.TO: 0.72 (-0.02)
IIROC Trade Halt - IMRIS Inc.
Newsfile Corp - Tue May 26, 7:24AM CDT
The following issues have been halted by IIROC:
IMRS: 0.02 (-0.01)
IMRIS Executive Vice Presidents of Global Sales and Global Customer Service Leave the Company
CNW Group - Tue May 19, 6:01AM CDT
IMRIS Inc. (NASDAQ: IMRS; TSX: IM) today announced that Mike Fritts, Executive Vice President, Global Customer Service, and Mark Reade, Executive Vice President, Global Sales, have left the Company. Mr. Fritts departed effective May 15, 2015 and has served as IMRIS' EVP of Global Customer Service since 2013. Mr. Reade departed effective May 16, 2015 and has served as IMRIS' EVP of Global Sales since 2010.
IMRS: 0.02 (-0.01), IM.TO: 0.72 (-0.02)
IMRIS Announces Correction of Annual Meeting Record Date to May 15, 2015
PR Newswire - Thu May 07, 3:31PM CDT
IMRIS Inc. (NASDAQ: IMRS; TSX: IM) ("IMRIS" or the "Company"
announces a correction to yesterday's press release which stated that the Company's shareholders of record on May 14, 2015 will be entitled to notice and to vote at the Annual Meeting. The record date is May 15, 2015 instead of May 14, 2015. IMRS: 0.02 (-0.01), IM.TO: 0.72 (-0.02)
IMRIS Announces Postponement of its Annual Meeting of Shareholders and Release of First Quarter 2015 Financial Results and Conference Call
PR Newswire - Wed May 06, 1:57PM CDT
IMRIS Inc. (NASDAQ: IMRS; TSX: IM) ("IMRIS" or the "Company"
today announced that the Annual Meeting of Shareholders, which was scheduled for May 7th, 2015, has been rescheduled to June 25th, 2015. IMRIS also announced that the First Quarter 2015 Financial Results press release and conference call, which were scheduled for May 7th, 2015, have been postponed. Further details regarding the meeting of shareholders will be contained in the Information Circular that will be mailed to shareholders of the Company in due course. IMRS: 0.02 (-0.01), IM.TO: 0.72 (-0.02)
IMRIS to Hold First Quarter 2015 Financial Results Conference Call
PR Newswire - Wed Apr 29, 4:45PM CDT
IMRIS Inc. (NASDAQ: IMRS; TSX: IM) IMRIS Inc. (the "Company" or "IMRIS"
is scheduled to release the Company's first quarter 2015 financial results on Thursday, May 7 at 8:00 a.m. Eastern time. A teleconference and a live webcast are scheduled that day from 9:00 to 10:00 a.m. Eastern time. You may join the teleconference by calling 1-800-505-9573 (US/CAN) or 1-416-204-9498 (Int'l), use conference ID 7822293. You may access the live webcast at www.imris.com/investors/events-and-presentations. IMRS: 0.02 (-0.01), IM.TO: 0.72 (-0.02)
North American Intraoperative Imaging Market by Type (Intraoperative CT, Intraoperative MRI, Intraoperative Ultrasound) - Forecast to 2019 with Medtronic Inc., Siemens AG, Brainlab AG Dominating
M2 - Tue Apr 28, 8:05AM CDT
Research and Markets (http://www.researchandmarkets.com/research/qnj4sj/north_american) has announced the addition of the "North American Intraoperative Imaging Market by Type (Intraoperative CT, Intraoperative MRI, Intraoperative Ultrasound) - Forecast to 2019" report to their offering. The Intraoperative Imaging market in North America is growing at 1.8% annually, with the U.S. having the largest market share and CAGR of 1.2 % among all countries, followed by Canada and Mexico The market has been divided into Intraoperative CT, Intraoperative MRI, and intraoperative ultrasound, wherein the intraoperative CT segment has highest market share while intraoperative MRI segment shows the highest growth rate among all three segments. There have been numerous opportunities for the market and the market players to grow and expand substantially. For example, Siemens AG shared its technology to integrate the hybrid suites and surgical theatre to enhance the operational efficiency of Sahlgrenaka University Hospital, one of the largest hospitals in Western Europe. There have been several collaborations among different market players to share their technologies and contribute to market growth. In addition, it is projected that the number of surgeries as well as healthcare expenditure will increase in coming years, which would have a positive impact on the growth of this market. However, high cost of automation is a factor that may inhibit the growth of this market in coming year. The report identified and analyses the various submarkets and highlights the high growth segments in this region. In addition, it includes profiles of the various companies operating in this market, along with a comprehensive analysis of the developments undertaken by them in recent years The key market players listed in this report include Medtronic Inc., Siemens AG, Brainlab AG, and others. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Market Overview 5 North Amrica Intraoperative Imaging Market, By Type 6 Intraoperative Imaging Market, By Country 7 Intraoperative Imaging Market: Competitive Landscape 8 Intraoperative Imaging Market, By Company - Brainlab Ag - Imris Inc. - Medtronic Plc - Neurologica Corporation - Philips Healthcare (A Subsidiary Of Royal Philips Electronics) - Siemens Ag For more information visit http://www.researchandmarkets.com/research/qn...h_american
PHG: 26.83 (+0.66), MDT: 85.51 (+1.25), IMRS: 0.02 (-0.01)
IMRIS Announces Receipt of Nasdaq Notice of Bid Price Deficiency
CNW Group - Wed Apr 22, 4:28PM CDT
IMRIS Inc. (NASDAQ: IMRS; TSX: IM) announced today that the Company received a letter, dated April 20, 2015, from the NASDAQ Stock Market LLC ("Nasdaq"
stating that for the previous 30 consecutive business days the bid price of the Company's common stock closed below the minimum $1.00 per share required for continued listing under Nasdaq Listing Rule 5450(a)(1). IMRS: 0.02 (-0.01), IM.TO: 0.72 (-0.02)
Leading neurosurgeons speaking on clinical utility of real-time navigated laser therapy for lesion ablation within Intraoperative MRI Suites at AANS
PR Newswire - Wed Apr 15, 7:25AM CDT
IMRIS, Monteris & MRI Interventions sponsoring luncheon seminar
IMRS: 0.02 (-0.01), IM.TO: 0.72 (-0.02)
Magnetic Resonance Imaging (MRI) Equipment - Global Strategic Business Report 2015-2020: GE Healthcare's Silent Scan Technology: A Major Technological Breakthrough
M2 - Wed Apr 01, 3:55AM CDT
Research and Markets (http://www.researchandmarkets.com/research/k89rwd/magnetic) has announced the addition of the "Magnetic Resonance Imaging (MRI) Equipment - Global Strategic Business Report" report to their offering. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. This report analyzes the worldwide markets for Magnetic Resonance Imaging (MRI) Equipment in Units and US$ Million by the following Product Segments: - Closed MRI Systems - Open MRI Systems. The US Market for MRI Equipment is separately analyzed by the following segments, categorized by magnetic field strength: - Low & Mid-Field Systems - High Field Systems - Very High-Field Systems. The report profiles 36 companies including many key and niche players such as: - China Resources Wandong Medical Equipment Co., Ltd. (China) - Esaote SPA (Italy) - FONAR Corporation (USA) - GE Healthcare (UK) - Hitachi Medical Corporation (Japan) - IMRIS, Inc. (US) - Medinus Co., Ltd. (South Korea) - Medtronic, Inc. (USA) - Philips Healthcare (US) - Shenzhen Anke High-tech Co., Ltd. (China) - Siemens Healthcare (Germany) - Toshiba Medical Systems Corp. (Japan) - Toshiba America Medical Systems, Inc. (US) Key Topics Covered: 1. MARKET OVERVIEW 2. MARKET TRENDS/DRIVERS/ISSUES 3. MRI EQUIPMENT: PRODUCT OVERVIEW 4. UTILITIES OF MRI EQUIPMENT 5. VERY HIGH FIELD SYSTEMS REDEFINING EFFICIENCY 6. COMPETITIVE IMAGING TECHNOLOGIES 7. PRODUCT INTRODUCTIONS/INNOVATIONS/ APPROVALS 8. RECENT INDUSTRY ACTIVITY 9. FOCUS ON SELECT PLAYERS 10. GLOBAL MARKET PERSPECTIVE Total Companies Profiled: 36 (including Divisions/Subsidiaries (51) - The United States (15) - Canada (1) - Japan (2) - Europe (19) - France (1) - Germany (6) - The United Kingdom (3) - Italy (2) - Rest of Europe (7) - Asia-Pacific (Excluding Japan) (12) - Middle East (2) For more information visit http://www.researchandmarkets.com/research/k89rwd/magnetic
MDT: 85.51 (+1.25), IMRS: 0.02 (-0.01), MDSY: 1.50 (+0.01)
